Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Dianah Linda Kasemire"'
Autor:
Dennis Mujuni, Dianah Linda Kasemire, Ivan Ibanda, Joel Kabugo, Andrew Nsawotebba, Jody E. Phelan, Robert Kaos Majwala, Didas Tugumisirize, Abdunoor Nyombi, Beatrice Orena, Irene Turyahabwe, Henry Byabajungu, Diana Nadunga, Kenneth Musisi, Moses Lutakoome Joloba, Willy Ssengooba
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Second-line drug resistance (SLD) among tuberculosis (TB) patients is a serious emerging challenge towards global control of the disease. We characterized SLD-resistance conferring-mutations among TB patients with rifampicin and/o
Externí odkaz:
https://doaj.org/article/b4fe0f0a25e346c2b75f7b87a1e86af9
Autor:
Dennis Mujuni, Willy Ssengooba, Ivan Ibanda, Joel Solomon Kabugo, Dianah Linda Kasemire, Elizabeth Nampewo, Andrew Nsawotebba, Jody E Phelan, Didas Tugumisirize, Beatrice Orena, Henry Byabajungu, Nathan Ntenkaire, Diana Nadunga, Julius Tumwine, Kenneth Musisi, Moses Joloba, Seungmo Kim, Ikwap Kokas, William Olaho Mukani, Joseph Kungu, Mathias Afayoa
Publikováno v:
F1000Research. 12:62
Background Increased tuberculosis disease burden arises as a result of low treatment success rates stemming from the emergence of second-line drug resistance. We aimed at determining the usefulness of second-line drug (SLD) resistance markers as prox
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4adf2fede9e6d475bb39e558e48bfa2
https://doi.org/10.12688/f1000research.129524.1
https://doi.org/10.12688/f1000research.129524.1
Autor:
Dennis Mujuni, Dianah Linda Kasemire, Ivan Ibanda, Joel Kabugo, Andrew Nsawotebba, Jody E. Phelan, Robert Kaos Majwala, Didas Tugumisirize, Abdunoor Nyombi, Beatrice Orena, Irene Turyahabwe, Henry Byabajungu, Diana Nadunga, Kenneth Musisi, Moses Lutakoome Joloba, Willy Ssengooba
Publikováno v:
BMC infectious diseases. 22(1)
Background Second-line drug resistance (SLD) among tuberculosis (TB) patients is a serious emerging challenge towards global control of the disease. We characterized SLD-resistance conferring-mutations among TB patients with rifampicin and/or isoniaz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f800f0e677fc672b7184842a4189ce10
https://pubmed.ncbi.nlm.nih.gov/35410160
https://pubmed.ncbi.nlm.nih.gov/35410160